The Global 3D Bioprinting Market is estimated to be worth USD 5.1 Billion by 2030, registering a 15.4% CAGR during the forecast period (2022- 2030).
The 3D Bioprinting method is an alternative to overcome the existing organ ongoing organ donation insufficiency crisis worldwide if 3D Bioprinters were able to print out any human organ. For instance, cohering to the U.S. Government Information on Organ Donation and Transplantation, more than 113,000 people are on the waiting list for national organ transplants as of July 2019. It causes the deaths of 20 patients per day due to the unavailability of organs for transplant. 3D Bioprinting can be a revelatory solution to the organ transplant waiting for crisis so that patients can receive organs for transplant in time. 3D Bioprinting technology has been applied in regenerative medicine with the help of 3D printed devices similar to surgical instruments and prosthetics. Presently, researchers are experimenting with bio-ink as a way of printing cartilage, bones, and vital organs.
The enhancement and degree of digitization in 3D biomaterials and Bioprinting is boosting at a high scale in the cosmetology and pharmaceutical industry and this factor is being supported by the rise of the availability of funds for the public and private sectors. Also, the arising support for Bioprinting research activities is on the roll that promises sound growth for 3D Bioprinting during the coming years.
Get FREE Sample copy of Report @ https://www.marketresearchfuture.com/sample_request/869
The Global 3D Bioprinting Market is divided into five regions; North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.
The North American market captured a revenue share of 31.6% in 2021 and is anticipated to lead throughout the forecast period. The augmenting incorporation of IT in the healthcare industry is estimated to stimulate the growth of the market over the forecast period. North America held the biggest market share worldwide. North America holds a considerable portion of the industry thanks to expressive public and private investments in the development of cutting-edge 3D Bioprinting technology.
Asia Pacific market is esteemed for a revenue share of23.7% of the 3D Bioprinting industry in 2021 and is anticipated to continue its dominance during the forecast period. Japan and China are considered the largest revenue share in the region.
The growing elderly population across the world is anticipated to drive the demand for orthopedic implants, as the risk of osteoarthritis, diabetes-related gangrene cases, and peripheral vascular disease is evolved among elderly individuals. The increasing aged population is anticipated to boost the revenue growth of the 3D Bioprinting market over the forecast period.
The global 3D Bioprinting Market is segmented into the following types;
By End User
The global 3D Bioprinting Market’s prominent key players are REGENHU Ltd. (Switzerland), Nano3D Biosciences Inc. (U.S.), FUJIFILM Wako Automation Corporation (U.S.), Organovo Holdings Inc. (U.S.), Allevi (U.S.), Regenovo Biotechnology Co. Ltd. (China), Stratasys Ltd. (U.S.), Aspect Biosystems Ltd. (Canada), Poietis (France), Envision TEC GmbH (Germany), Cellink AB (Sweden), Cyfuse Biomedical K.K. (Japan).
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/3d-bioprinting-market-869
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
More Related Report
Medical Devices Market Research Report – Global Forecast till 2030
India CRO Market Research Report – Global Forecast till 2030
India Diabetes Market Research Report – Global Forecast till 2030